reported side effects of enoxaparin
anemia
hemorrhage
other side effects
fever
comprehensive list of adverse effects
hematologic side effects
wound hematoma
anemia
ecchymosis
thrombocytopenia
thrombocytosis
hemarthrosis
thrombosis
hypochromic anemia
retroperitoneal hematoma
clinical trials experience
reports of spinal/epidural hematoma
risk of hemorrhage
postmarketing
postmarketing side effects
hemorrhagic anemia
eosinophilia
patients
undergoing spinal/epidural anesthesia
puncture
low molecular weight heparins
heparinoids
risk for long-term
permanent paralysis
spinal hematoma
risk of these events
use
indwelling
indwelling epidural catheters
concomitant use of platelet inhibitors
other anticoagulants
drugs
hemostasis
clinical study
younger patients
incidence
bleeding complications
patients
patients
unfractionated heparin
low-molecular-weight heparin
developing
developing heparin-induced thrombocytopenia
hit
hit-related thromboembolic complications
transient ischemic attack
stroke
heparin-induced thrombocytopenia
hit
prothrombotic reaction
patients
unfractionated heparin
patients
low molecular weight heparin
lmwh
decrease in platelet count
hit
days
starting heparin
patients with a previous exposure
heparin
abrupt decrease in platelets
restarting heparin
patients with lmwh-induced hit
longer delay in the onset of symptoms
unfractionated heparin
following discontinuation
platelet
days
weeks in patients with high-titer hit antibodies
thrombocytopenia
heparin-dependent igg antibodies
specific platelet protein
platelet factor
pf
heparin-pf-igg
immune complex
platelets
causing platelet activation
activated platelets
release of platelet-derived procoagulant microparticles
coagulation reactions
thrombin
lmwhs
high cross-reactivity
circulating
circulating heparin-pf-igg immune complex
factors
higher risk
developing
developing hit-associated thrombosis
women
nonwhites
severity of thrombocytopenia
lower body weight
complications
hit
exacerbation of venous thromboembolism
venous thrombosis
limb gangrene
stroke
skin necrosis
antibodies
hit
months
use of unfractionated heparin
lmwh
patient with a history of hit if the antibody test
factors
increased risk
bleeding
high doses
age
renal dysfunction
concomitant use of other drugs
hemostasis
hepatic side effects
transient elevations in liver function tests
postmarketing
postmarketing side effects
cholestatic liver injury
local side effects
pain
erythema
ecchymosis
hematoma
red induration
necrotic ulcerations at the injection site
skin necrosis
injection site
skin necrosis
heparin-associated thrombocytopenia
thrombosis syndrome
complication
enoxaparin
unfractionated heparin
recent report
occurrence of skin necrosis
associated thrombocytopenia with low molecular weight heparin use
late-onset skin necrosis
thrombocytopenia
thromboembolism
use
immediate discontinuation of low-molecular weight heparin
order
fatal thromboembolic complications
hypersensitivity side effects
systemic allergic reactions
pruritus
urticaria
anaphylactic/anaphylactoid reactions
shock
postmarketing experience
case of angioedema
dermatologic side effects
vesiculobullous rash
purpura
cutaneous vasculitis
cases of bullous pemphigoid-like eruption
rare case of enoxaparin-induced ischemic skin necrosis
postmarketing
postmarketing side effects
alopecia
respiratory side effects
lung edema
pneumonia
dyspnea
cardiovascular
side effects
atrial fibrillation
heart failure
edema
peripheral edema
gastrointestinal side effects
nausea
diarrhea
metabolic side effects
hyperlipidemia
postmarketing reports
cases of hyperkalemia
reports
patients
conditions
development of hyperkalemia
renal dysfunction
concomitant potassium-sparing drugs
administration of potassium
hematoma in body tissues
case of hyperlipidemia with marked hypertriglyceridemia
diabetic pregnant woman
causality
genitourinary side effects
hematuria
nervous system
side effects
confusion
postmarketing reports of headache
other side effects
fever
hemorrhagic side effects
patients
meta-analysis
published studies
overall incidence of major bleeding with low molecular weight heparins
hemorrhage
site in the body
unexplained decrease in blood pressure
hematocrit
unexplained symptoms
consideration of a possible hemorrhagic event
study
involving pregnant women
n =-rrb-
requiring thromboprophylaxis
significant bone loss
i.
e.
femur
patients
enoxaparin
mg/day
unfractionated heparin
units/day
weeks
musculoskeletal side effects
osteoporosis
bleeding gums
coughing up blood
difficulty with breathing
swallowing
dizziness
headache
increased menstrual flow
vaginal bleeding
nosebleeds
paralysis
prolonged bleeding from cuts
tarry stools
dark brown urine
shortness of breath
bruising
chest discomfort
collection of blood under the skin
confusion
continuing bleeding
oozing from the nose
mouth
surgical wound
convulsions (seizures)
fever
irritability
lightheadedness
lower back pain
pain
burning
urinating
swelling of the hands
feet
tightness in the chest
uncontrolled bleeding at the site of injection
vomiting of blood
material
coffee grounds
wheezing
back pain
burning
pricking
tickling
tingling sensation
chest pain
chills
cough
decreased urine output
dilated neck veins
dizziness
lightheadedness
getting
lying
sitting position
extreme fatigue
fainting
irregular heartbeat
general feeling of discomfort
illness
irregular breathing
leg weakness
problems with bowel
bladder function
skin rash
hives
sneezing
sore throat
sudden fainting
swelling of the face
fingers
feet
genitals
mouth
tongue
thickening of the bronchial secretions
troubled breathing
weight gain
stomach pain
dark purple bruise
hives or welts
irregular heartbeat
itching
pain
redness
swelling
purplish patches in the skin
nausea or vomiting
nervousness
numbness
tingling in the hands
feet
lips
puffiness
swelling of the eyelids
eyes
face
lips
tongue
redness of the skin
skin rash
unusual tiredness
weakness
weakness
heaviness of the legs
diarrhea
irritation
pain
redness at the place of injection